Announcements Trials
Browse Landscape

Phase

Phase 4 5Phase 2 3Phase NA 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Tobacco Use Cessation 1Health Education 1

Interventions

Cyclophosphamide 143pembrolizumab 127Nivolumab 116Carboplatin 99Dexamethasone 93Rituximab 91Paclitaxel 87Gemcitabine 85Lenalidomide 75Cytarabine 74Radiotherapy 73Cisplatin 70Bevacizumab 64Etoposide 62fludarabine phosphate 58fludarabine 56Ipilimumab 55Docetaxel 54Bortezomib 54Prednisone 49Doxorubicin 48Temozolomide 47Everolimus 46Erlotinib Hydrochloride 46Fluorouracil 44Azacitidine 44Capecitabine 43Calcium Dobesilate 43Filgrastim 42Melphalan 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Has results × Tobacco Use Cessation Devices × Clear all
NCT02596711 2020-03-10

Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers

M.D. Anderson Cancer Center

Phase 1/2 Completed
26 enrolled 10 charts

Health Education, Tobacco Use Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡